Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Data Brief ; 36: 107074, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34026973

ABSTRACT

There had been an urgent call for the collection of standardized data describing clinical presentations, severity, outcomes, and epidemiology of COVID-19 by the World Health Organization (WHO). These data were expected to compliment the national pandemic data collated from countries by the World Health Organization (WHO). Nigeria, among other countries, is not an exception. This survey collected data on the respondent's knowledge on COVID-19, their attitude and practices towards the control of the spread of COVID-19 amongst Nigerians. The data were collected through an online survey. There were 1320 respondents from Nigeria that answered the survey questions. The survey was conducted between March 31 and April 28, 2020 which were within the lockdown period in the country. These data could serve as auxiliary information and/or research data for other researchers in Nigeria. It could also serve as guide or reference data to other researchers outside Nigeria who may be interested in carrying out similar research in another country.

2.
Biotechnol Rep (Amst) ; 27: e00513, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32923377

ABSTRACT

This study aims to screen bacterial isolates from Olabisi Onabanjo University Farmland for antibacterial activity against pathogenic microorganisms. Agar well diffusion method was used. Isolates were identified molecularly. Chi-square test revealed significant association between isolates, antibacterial activity with likelihood p-value = 0.000 and 5% significant level. Six among thirty-five isolates exhibited antibacterial activity against the test pathogenic species. A greater antibacterial activity (50 % inhibition) was observed in Lysinibacillus sphearicus strain PRE16. It inhibited the growth of Bacillus subtilis, Staphylococcus aureus and Escherichia coli by 23.00 ± 2.00, 18.00 ± 2.00 and 20.00 ± 4.00 respectively. DNA sequencing revealed antagonist isolates as Bacillus sp. BCN2, Brochothrix thermosphacta strain P30C4, Bacillus aryabhattai strain KNUC205, Alcaligenes faecalis strain KEM24, Bacillus arsenicus strain CSD05 and Lysinibacillus sphaericus strain PRE16. Phylogenetic analysis revealed close relatedness of most isolates with Bacillus species strains. These strains are suggested to be effective for the discovery of new antibacterial agents.

SELECTION OF CITATIONS
SEARCH DETAIL
...